Benign neoplasm: Caecum

CD2_BENIGN_CAECUM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12.0& Hospital discharge: ICD-8 — 21132 Cause of death: ICD-10 — D12.0& Cause of death: ICD-8 — 21132 2 out of 7 registries used, show all original rules.	4202
4. Check minimum number of events None	4202
5. Include endpoints None	4202
6. Filter based on genotype QC (FinnGen only)	4088

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D12
Name in latin: Neoplasma benignum caeci

NAME	CD2_BENIGN_CAECUM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D120
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21132
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D120
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21132
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Caecum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17590	9035	8500
Only index persons	16774	8728	8046
Unadjusted period prevalence (%)
Whole population	0.25	0.26	0.24
Only index persons	0.31	0.32	0.31
Median age at first event (years)
Whole population	69.48	69.23	69.74
Only index persons	69.27	69.08	69.49

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4088	2097	1991
Unadjusted period prevalence (%)	0.83	0.74	0.91
Median age at first event (years)	68.98	67.97	70.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4202: Matched controls
42020

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.1

307.7

1697

5958

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

18.0

307.7

1615

1411

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

6.6

307.7

756

1352

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

157649.6

307.7

4181

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

13.5

307.7

431

352

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

10.3

307.7

834

991

UJF32

NOMESCO Finland

Coloscopy

12.6

307.7

3183

8344

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

13.2

307.7

391

323

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

18.6

307.7

971

667

UJF30

NOMESCO Finland

Ileoscopy through colon

5.9

307.7

1163

2580

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

9.1

307.7

704

905

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

16.9

307.7

704

494

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

286.7

2009

9449

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

12.1

266.6

273

239

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

98.2

184.7

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.4

153.2

638

2119

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

134.1

1502

8179

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

7.2

129.9

198

288

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

127.1

1743

10255

JFA42

NOMESCO Finland

Endoscopic injection in colon

16.1

112.2

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

13.7

109.3

102

K63.5

ICD-10 Finland

Polyp of colon

5.6

108.9

212

394

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

93.9

706

3167

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.1

87.3

402

1398

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

15.1

82.8

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

6.8

82.3

130

196

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.1

79.9

364

1257

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

78.4

667

3143

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

77.8

2313

16842

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.7

75.2

461

1864

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

74.3

1117

6533

A02BC02

ATC

pantoprazole; systemic

1.9

70.8

3075

24797

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

9.8

69.0

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

63.1

453

1969

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

62.7

901

5150

B01AB05

ATC

enoxaparin; parenteral

1.8

61.9

1568

10664

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

61.4

550

2631

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

59.6

466

2103

N02BE01

ATC

paracetamol; systemic, rectal

2.4

58.4

3836

34134

JN4AD

NOMESCO Finland

Body CT examination

2.1

58.1

596

3007

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

10.3

55.5

K64.0

ICD-10 Finland

First degree haemorrhoids

4.4

53.7

138

324

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

7.2

52.9

112

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

52.9

601

3144

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

10.0

52.5

UJH02

NOMESCO Finland

Anoscopy

3.0

51.6

243

851

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

14.0

51.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

50.8

651

3552

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

49.1

524

2674

P01AB01

ATC

metronidazole; oral, rectal

1.6

47.6

1638

11859

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.5

47.1

167

493

JFB30

NOMESCO Finland

Right hemicolectomy

4.5

47.0

117

268

K92.1

ICD-10 Finland

Melaena

2.5

46.5

316

1334

WX002

NOMESCO Finland

Sedation and analgesia

1.8

46.1

952

6017

A02BC05

ATC

esomeprazole; systemic

1.6

45.8

1771

13154

A02BC03

ATC

lansoprazole; oral

1.6

44.0

1303

9048

SPAT1104

SPAT

Monitoring of emergency patient

2.3

43.3

353

1615

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

5.9

43.1

135

J01DB01

ATC

cefalexin; oral

1.7

42.7

3406

29831

JN4BD

NOMESCO Finland

Extensive body CT

1.9

42.7

566

3113

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

5.4

42.2

159

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

42.1

1011

6640

N02AX02

ATC

tramadol; systemic, rectal

1.5

40.2

1881

14450

H02AB06

ATC

prednisolone; systemic

1.5

40.1

2026

15826

JFB20

NOMESCO Finland

Ileocaecal resection

7.6

39.4

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

37.9

1133

7830

UJF92

NOMESCO Finland

Capsular endoscopy

3.6

37.9

129

371

8263/2-C18.0

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of cecum

103.5

37.8

C05AA08

ATC

fluocortolone; rectal, topical

1.8

37.7

632

3737

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

37.6

1498

11061

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

37.2

1291

9235

S18

ICPC

Laceration/cut

1.5

36.2

2031

16090

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

36.1

426

2243

R06.0

ICD-10 Finland

Dyspnoea

1.6

36.1

1224

8696

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

35.7

284

1284

A07EC02

ATC

mesalazine; oral, rectal

2.5

35.1

238

1002

C03CA01

ATC

furosemide; systemic

1.5

34.8

1458

10836

D01

ICPC

Abdominal pain/cramps general

1.9

34.7

471

2600

AA1AD

NOMESCO Finland

CT of head and brain

1.5

34.0

1284

9322

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

33.9

875

5811

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

33.6

1602

12214

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.2

33.0

131

415

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3.7

32.5

103

282

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.1

32.4

216

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

5.7

32.0

104

C07AB07

ATC

bisoprolol; oral

1.5

31.5

2239

18391

M54.5

ICD-10 Finland

Low back pain

1.5

31.3

1380

10312

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.1

31.3

136

455

J01CA04

ATC

amoxicillin; systemic

1.6

31.1

3192

28190

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

30.9

690

4403

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

30.7

548

3287

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

30.7

458

2603

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

30.5

1524

11667

J01MA12

ATC

levofloxacin; systemic

1.6

29.9

839

5664

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

29.8

449

2558

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.5

29.8

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.7

29.7

167

642

SPAT1153

SPAT

Removal of sutures

1.5

29.7

1438

10926

G47.3

ICD-10 Finland

Sleep apnoea

1.6

29.4

929

6446

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

29.0

231

1043

J01AA02

ATC

doxycycline; systemic

1.5

28.9

3187

28280

UKC02

NOMESCO Finland

Cystoscopy

1.6

28.8

786

5266

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

28.6

770

5142

N03AX16

ATC

[U] pregabalin

1.5

28.6

995

7048

R03AC02

ATC

salbutamol; inhalant

1.4

28.2

2092

17170

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

28.1

1066

7687

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4.0

28.1

208

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

27.9

709

4666

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.4

27.8

101

303

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.3

27.8

228

1043

A02BC04

ATC

rabeprazole; oral

1.9

27.4

365

1997

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.6

27.4

159

621

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

27.3

1655

13070

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

27.2

334

1778

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

27.1

434

2517

A98

ICPC

Health maint/preventive medicine

2.2

27.0

3988

37657

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.8

26.9

137

501

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

26.8

196

853

-, ,

ICD-10 Finland

3.0

26.8

121

414

C180, 8211, 2

ICD-O-3

272.8

26.7

JAH01

NOMESCO Finland

Laparoscopy

2.5

26.6

175

727

K55.2

ICD-10 Finland

Angiodysplasia of colon

5.1

26.5

112

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

26.3

769

5225

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

26.3

178

749

WX402

NOMESCO Finland

General anaesthesia

1.6

26.2

821

5669

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

25.2

336

1839

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

25.2

316

1695

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

25.2

470

2848

Z2221

NOMESCO Finland

Medical doctor

1.5

25.1

1069

7862

SPAT1263

SPAT

Sampling

1.4

25.1

1665

13300

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

24.9

830

5799

A06AC51

ATC

ispaghula, combinations; oral

2.2

24.7

225

1073

M79.6

ICD-10 Finland

Pain in limb

1.4

24.3

1635

13071

XKD00

NOMESCO Finland

Uroflowmetry

1.5

24.2

767

5298

UJG02

NOMESCO Finland

Proctoscopy

2.9

24.1

115

406

D06

ICPC

Abdominal pain localized other

1.9

24.0

340

1896

A02BC01

ATC

omeprazole; systemic

1.5

23.9

1138

8543

J01MA02

ATC

ciprofloxacin; systemic

1.4

23.8

1627

13028

N06AX11

ATC

mirtazapine; oral

1.4

23.5

1310

10116

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

23.4

2696

23544

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

5.5

23.3

K64.1

ICD-10 Finland

Second degree haemorrhoids

3.1

23.3

317

D11

ICPC

Diarrhoea

1.8

23.0

390

2298

J01FA06

ATC

roxithromycin; oral

1.4

22.9

1548

12348

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.7

22.8

128

492

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

22.8

1580

12659

B01AB10

ATC

tinzaparin; parenteral

1.7

22.8

445

2728

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

22.5

775

5441

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

22.5

1923

15939

B01AA03

ATC

warfarin; systemic

1.5

22.4

890

6435

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.1

22.3

213

1035

R06AE07

ATC

cetirizine; oral

1.4

22.3

1578

12674

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

5.6

22.2

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

22.2

357

2069

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

22.1

756

5299

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

22.1

215

1053

B80

ICPC

Iron deficiency anaemia

2.7

21.6

113

419

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

21.6

205

994

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

21.4

1218

9407

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

21.3

608

4091

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.5

21.0

115

G04CA02

ATC

tamsulosin; oral

1.4

21.0

1090

8280

207

Kela drug reimbursment

Chronic arrhythmias

1.5

20.9

762

5407

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

20.8

303

1703

R19.4

ICD-10 Finland

Change in bowel habit

2.5

20.8

134

551

-60

ICPC

Result test/procedure

1.9

20.8

258

1378

SPAT1254

SPAT

Administration of medicine

1.6

20.6

607

4112

SPAT1216

SPAT

Assessment of functional ability

1.5

20.6

703

4917

SPAT1097

SPAT

Recording of ECG

1.5

20.6

661

4563

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

20.6

533

3506

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

5.5

20.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

20.5

697

4871

H02AB04

ATC

methylprednisolone; systemic

1.6

20.3

580

3900

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

20.3

911

6731

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

20.1

342

2014

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

20.1

659

4570

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.5

19.9

127

520

SPAT1301

SPAT

No procedures

1.4

19.9

1278

10050

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

19.8

1730

14288

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

19.8

1061

8089

R01AD09

ATC

mometasone; nasal

1.4

19.7

1586

12928

K30

ICD-10 Finland

Functional dyspepsia

1.7

19.7

431

2718

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

19.6

233

1227

A07EA06

ATC

budesonide; oral, local oral

2.3

19.5

142

618

N03AX12

ATC

[U] gabapentin; oral

1.5

19.4

666

4659

B01AF02

ATC

apixaban; oral

1.5

19.4

610

4189

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.2

19.4

235

L17

ICPC

Foot/toe symptom/complaint

1.4

19.4

1150

8919

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

19.3

1014

7698

R42

ICD-10 Finland

Dizziness and giddiness

1.4

19.2

947

7107

L03

ICPC

Low back symptom/complaint

1.4

19.1

1025

7806

A04

ICPC

Weakness/tiredness general

1.6

19.1

554

3737

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

19.0

164

766

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

18.9

338

2020

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

18.7

630

4386

R02

ICPC

Shortness of breath/dyspnoea

1.6

18.7

546

3686

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

18.7

489

3221

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.7

18.7

R53

ICD-10 Finland

Malaise and fatigue

1.4

18.6

882

6565

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.9

18.6

144

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

18.5

549

3721

D16

ICPC

Rectal bleeding

2.5

18.3

111

444

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.2

18.3

152

700

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

18.3

589

4063

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

18.2

338

2041

D19

ICPC

Teeth/gum symptom/complaint

1.4

18.1

934

7059

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

17.9

338

2049

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.8

17.9

339

R03BB04

ATC

tiotropium bromide; inhalant

1.6

17.9

450

2936

K51.5

ICD-10 Finland

Left sided colitis

2.6

17.8

103

403

D12

ICPC

Constipation

2.1

17.8

168

814

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

13.7

17.7

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

20.1

17.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

17.7

275

1577

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

17.6

256

1438

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

17.6

1110

8670

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

17.6

199

1030

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

17.5

169

825

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

17.5

438

2854

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

17.3

255

1438

R4110

NOMESCO Finland

Physiotherapy

1.4

17.3

1109

8680

A06AD11

ATC

lactulose; oral

1.5

17.2

621

4382

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

3.2

17.2

211

S29

ICPC

Skin symptom/complaint other

1.4

17.2

768

5647

B01AF01

ATC

rivaroxaban; oral

1.5

17.2

591

4129

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

17.1

137

621

SPAT1255

SPAT

Intravenous administration of medicine

1.7

17.0

296

1753

E0000UV, ,

ATC

1.3

17.0

1540

12700

L01BC06

ATC

capecitabine; oral

2.0

17.0

183

930

Z3231

NOMESCO Finland

Registered nurse

1.4

17.0

1079

8428

C180, 8148, 2

ICD-O-3

50.2

17.0

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

16.8

288

1699

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

16.7

163

799

ZX120

NOMESCO Finland

Intravenous

1.6

16.7

392

2512

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.6

16.6

393

D02

ICPC

Abdominal pain epigastric

1.9

16.6

226

1244

L04AX01

ATC

azathioprine; systemic

2.1

16.5

163

804

C10AC01

ATC

colestyramine; oral

2.4

16.4

117

505

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

16.4

1752

14772

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

16.4

1019

7925

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

20.1

16.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

16.4

1500

12375

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.7

16.3

J45

ICD-10 Finland

Asthma

1.6

16.3

369

2344

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

16.2

226

1253

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

16.2

1038

8113

H02AB07

ATC

prednisone; oral

1.5

16.1

540

3749

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

16.1

564

3954

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

16.0

803

6019

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

16.0

156

765

M48.0

ICD-10 Finland

Spinal stenosis

1.5

16.0

557

3898

JFB43

NOMESCO Finland

Left hemicolectomy

4.3

15.9

J02AC01

ATC

fluconazole; systemic

1.3

15.9

1308

10611

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.1

15.9

156

767

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

15.9

134

621

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

3.3

15.8

176

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

5.3

15.6

T90

ICPC

Diabetes non-insulin dependent

1.4

15.5

1030

8085

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

15.5

1973

16994

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.0

15.4

R03BA02

ATC

budesonide; inhalant

1.5

15.3

629

4546

N05CF01

ATC

zopiclone; oral

1.3

15.3

1271

10315

J46

ICD-10 Finland

Status asthmaticus

2.3

15.2

119

535

A07EA02

ATC

hydrocortisone; rectal

2.6

15.2

345

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

15.2

1121

8939

K62.1

ICD-10 Finland

Rectal polyp

3.3

15.1

171

JN4CD

NOMESCO Finland

Very extensive body CT

2.0

15.1

173

899

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

15.1

195

1056

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

15.1

2686

24155

SPAT1260

SPAT

Consultation of another employee

1.4

15.0

693

5113

B82

ICPC

Anaemia other/unspecified

2.2

15.0

131

616

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

4.0

14.9

102

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

14.9

585

4188

M03BX02

ATC

tizanidine; oral

1.3

14.9

2238

19657

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.1

14.8

204

-48

ICPC

Clarification/discussion RFE/demand

2.7

14.8

298

JF2BD

NOMESCO Finland

Extensive colon CT

3.4

14.6

150

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

14.6

152

764

M01AH05

ATC

etoricoxib; oral

1.3

14.6

2273

20034

21132

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Caeci

+∞

14.6

R03AC03

ATC

terbutaline; inhalant

1.5

14.6

494

3435

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

14.6

435

2945

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

14.6

747

5613

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.5

14.5

146

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.6

14.5

324

ZXD05

NOMESCO Finland

Urgent procedure

1.3

14.5

1102

8816

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

14.5

540

3828

WVA20

NOMESCO Finland

Medicine administration

2.3

14.4

109

483

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

14.4

302

1881

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

14.4

639

4681

R03BA05

ATC

fluticasone; inhalant

1.4

14.3

631

4615

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

14.3

563

4032

R51.80

ICD-10 Finland

Headache

1.5

14.3

492

3432

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

14.3

267

1614

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

14.3

175

932

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.9

14.2

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.3

14.2

102

442

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

14.2

104

455

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

14.2

317

2007

K78

ICPC

Atrial fibrillation/flutter

1.6

14.1

361

2360

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

5.7

14.1

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

14.1

425

M79.1

ICD-10 Finland

Myalgia

1.5

14.1

484

3374

G04BD12

ATC

mirabegron; oral

1.5

14.1

533

3788

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.3

14.1

101

438

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

14.1

475

3300

S82

ICPC

Naevus/mole

1.5

14.0

497

3487

K59.0

ICD-10 Finland

Constipation

1.8

14.0

226

1311

N06AX21

ATC

duloxetine; oral

1.5

14.0

405

2723

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

14.0

812

6226

R52.9

ICD-10 Finland

Pain, unspecified

1.6

13.9

362

2377

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

13.9

365

2402

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

13.9

253

1519

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

13.8

293

1831

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

13.7

1054

8431

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

13.7

1436

11992

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

13.7

2549

22898

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

13.7

282

1749

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

13.7

979

7751

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

5.7

13.7

SPAT1325

SPAT

Vaccination

1.3

13.6

1376

11434

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

13.6

768

5859

A03FA02

ATC

cisapride; oral, rectal

1.6

13.6

298

1878

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

13.6

631

4657

R03DC03

ATC

montelukast; oral

1.4

13.5

548

3945

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

13.4

282

1757

WX722

NOMESCO Finland

PEEP

1.8

13.4

190

1060

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

13.4

504

3576

A10BA02

ATC

metformin; oral

1.3

13.4

1175

9574

-34

ICPC

Blood test

2.1

13.4

121

578

SPAT1312

SPAT

General health counselling

1.3

13.3

1150

9350

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.3

1424

11917

C03DA01

ATC

spironolactone; oral

1.5

13.3

501

3558

J01FF01

ATC

clindamycin; systemic

1.3

13.3

1006

8028

C10AA05

ATC

atorvastatin; oral

1.3

13.2

1824

15756

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.6

13.2

286

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

4.2

13.1

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.9

13.1

219

J01MA14

ATC

moxifloxacin; systemic

1.6

13.1

350

2310

G44.2

ICD-10 Finland

Tension-type headache

1.5

13.1

444

3086

A10AE04

ATC

insulin glargine; parenteral

1.5

13.1

379

2549

SFA10

NOMESCO Finland

One-surface restoration

1.3

13.1

1906

16570

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

13.1

673

5054

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

13.0

434

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

13.0

378

2542

-35

ICPC

Urine test

3.1

13.0

167

U02

ICPC

Urinary frequency/urgency

1.4

13.0

529

3809

A10BH01

ATC

sitagliptin; oral

1.5

13.0

412

2824

U07

ICPC

Urine symptom/complaint other

1.6

12.9

300

1916

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.3

12.9

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

12.8

248

1513

L13

ICPC

Hip symptom/complaint

1.4

12.8

743

5688

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

12.7

123

603

F29

ICPC

Eye symptom/complaint other

1.6

12.7

339

2238

B01AB04

ATC

dalteparin; parenteral

1.7

12.6

210

1229

R50.9

ICD-10 Finland

Fever, unspecified

1.4

12.6

537

3897

R13

ICD-10 Finland

Dysphagia

1.6

12.6

284

1802

Z3226

NOMESCO Finland

Physiotherapist

1.4

12.5

693

5262

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

12.5

2276

20278

-45

ICPC

Observ/health educat/advice/diet

2.1

12.5

123

607

-50

ICPC

Medication/prescr/renewal

1.8

12.4

169

931

Z01.2

ICD-10 Finland

Dental examination

1.3

12.4

1518

12891

SDA03

NOMESCO Finland

Periodontal treatment

1.3

12.4

1333

11137

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

4.4

12.4

A11

ICPC

Chest pain NOS

1.6

12.3

337

2236

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.7

12.3

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

12.3

166

912

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

12.3

676

5127

TK800

NOMESCO Finland

Hemodialysis

2.3

12.3

407

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

3.6

12.3

108

R35

ICD-10 Finland

Polyuria

1.6

12.3

287

1837

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.1

12.2

121

598

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

12.2

823

6442

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

12.2

1361

11416

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

12.2

682

5186

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

12.2

695

5301

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.6

12.2

257

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

12.2

1206

9964

J01DA01

ATC

[U] cefalexin

1.3

12.1

2291

20468

WX290

NOMESCO Finland

Other blockage of nerve

1.3

12.1

1415

11939

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

12.1

131

670

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

12.0

725

5580

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

12.0

1118

9159

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

12.0

237

1455

JF1AD

NOMESCO Finland

Small bowel CT

3.6

12.0

110

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.2

12.0

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

11.9

1390

11721

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.8

11.8

175

991

A10BH05

ATC

linagliptin; oral

1.7

11.8

226

1376

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

11.8

401

2788

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

11.8

1389

11721

M01AE02

ATC

naproxen; oral, rectal

1.3

11.8

2003

17652

K96

ICPC

Haemorrhoids

2.2

11.8

460

X58

ICD-10 Finland

Exposure to other specified factors

1.5

11.8

449

3192

I50

ICD-10 Finland

Heart failure

2.0

11.8

133

690

A05

ICPC

Feeling ill

1.8

11.8

166

926

R07.3

ICD-10 Finland

Other chest pain

1.5

11.7

388

2682

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

11.7

231

1417

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

3.8

11.7

A01

ICPC

Pain general/multiple sites

1.5

11.7

345

2328

-31

ICPC

Medical examin/health eval partial

1.6

11.7

260

1644

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

11.7

992

8021

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.7

11.6

196

1152

XF404

NOMESCO Finland

Ambulatory ECG

1.5

11.5

366

2511

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.1

11.5

102

485

J20

ICD-10 Finland

Acute bronchitis

1.5

11.4

349

2375

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

11.4

443

3162

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

11.4

159

885

-62

ICPC

Administrative procedure

2.0

11.3

112

554

ZXA00

NOMESCO Finland

Right side

1.3

11.3

1060

8679

R15

ICD-10 Finland

Faecal incontinence

2.0

11.3

124

637

R31

ICD-10 Finland

Unspecified haematuria

1.5

11.3

426

3021

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

11.3

976

7906

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

8.3

11.3

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.8

11.2

179

1036

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

11.2

231

1434

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

11.2

116

584

8263/2-C18.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS

17.1

11.2

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

11.2

119

605

M54.2

ICD-10 Finland

Cervicalgia

1.6

11.1

267

1720

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

11.1

119

606

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

3.1

11.1

146

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

11.1

289

1898

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

11.0

380

2648

I84

ICD-10 Finland

Hemorrhoids

2.0

11.0

112

560

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.7

11.0

198

1186

UJF30, ,

SPAT

3.1

11.0

147

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

11.0

183

1073

D18

ICPC

Change in faeces/bowel movements

2.1

11.0

100

480

EMAK, ,

NOMESCO Finland

1.9

11.0

128

672

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

11.0

1276

10729

JG1JG

NOMESCO Finland

MRI of rectal function (MR defecography)

4.7

10.9

R01AD58

ATC

fluticasone, combinations; nasal

1.3

10.9

685

5300

K29.8

ICD-10 Finland

Duodenitis

3.1

10.8

143

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

10.8

271

1763

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

10.8

303

UJF34

NOMESCO Finland

Left colonoscopy

3.4

10.8

108

A07AA09

ATC

vancomycin; oral

2.5

10.8

255

R04

ICPC

Breathing problem other

1.9

10.8

139

754

C09CA06

ATC

candesartan; oral

1.3

10.8

870

6978

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

10.7

496

3649

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

10.7

293

1944

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

10.7

150

835

M25.5

ICD-10 Finland

Pain in joint

1.3

10.7

1087

8980

J01FA10

ATC

azithromycin; systemic

1.2

10.7

1906

16814

L05

ICPC

Flank/axilla symptom/complaint

1.6

10.7

228

1427

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

10.7

912

7366

D64.8

ICD-10 Finland

Other specified anaemias

2.3

10.7

361

L86

ICPC

Back syndrome with radiating pain

1.6

10.7

221

1373

R05

ICD-10 Finland

Cough

1.3

10.6

779

6161

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

10.6

638

4899

L04

ICPC

Chest symptom/complaint

1.6

10.6

225

1407

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

10.6

265

1724

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

3.1

10.6

140

SPAT1262

SPAT

Handing over of treatment supplies

1.3

10.6

707

5518

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

10.5

228

1433

N02BF01

ATC

gabapentin; oral

1.5

10.5

296

1977

N01

ICPC

Headache

1.6

10.5

276

1817

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.4

1182

9894

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

10.4

199

1211

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

10.4

242

1547

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

10.4

213

1320

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

2.4

10.4

284

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

5.4

10.4

K62.3

ICD-10 Finland

Rectal prolapse

2.6

10.4

219

WX892

NOMESCO Finland

Monitored bed care

1.5

10.4

296

1984

JF1BD

NOMESCO Finland

Very extensive small bowel CT

3.6

10.3

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

10.3

153

867

-42

ICPC

Electrical tracing

2.4

10.3

279

E000001, ,

ATC

1.3

10.3

650

5028

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

10.3

836

6705

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

10.3

1632

14200

SPAT1167

SPAT

Insertion of urinary catheter

1.8

10.2

138

760

WX004

NOMESCO Finland

Patient-controlled sedation

3.8

10.2

K60.1

ICD-10 Finland

Chronic anal fissure

2.2

10.2

382

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

2.9

10.2

165

UJD02

NOMESCO Finland

Gastroscopy

1.7

10.2

189

1143

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.9

10.1

126

676

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

3.7

10.1

G04CA01

ATC

alfuzosin; oral

1.4

10.1

517

3869

XF402

NOMESCO Finland

ECG with work load test

1.4

10.1

441

3212

J33.8

ICD-10 Finland

Other polyp of sinus

2.2

10.1

383

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

10.1

356

2492

J05AB11

ATC

valaciclovir; oral

1.4

10.1

501

3732

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.8

10.0

177

L15

ICPC

Knee symptom/complaint

1.3

10.0

876

7091

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

10.0

247

1602

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

10.0

177

1057

C01DA14

ATC

isosorbide mononitrate; oral

1.3

10.0

656

5106

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

9.9

3423

32395

R03BA08

ATC

ciclesonide; inhalant

1.5

9.9

292

1970

JG1BG

NOMESCO Finland

MRI of rectum

3.1

9.9

130

M04AA01

ATC

allopurinol; systemic

1.4

9.9

549

4163

L08

ICPC

Shoulder symptom/complaint

1.3

9.9

811

6510

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

9.9

239

1544

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

9.9

302

2055

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

9.8

162

949

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

9.8

984

8108

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

9.8

905

7379

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.1

9.8

408

M01AX17

ATC

nimesulide; oral

1.3

9.8

934

7648

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

9.7

268

1783

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.0

9.7

476

JFA15, ,

SPAT

3.2

9.7

116

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

9.7

740

5882

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

9.6

941

7722

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.6

1110

9299

A99

ICPC

Disease/condition unspecnature/site

1.5

9.6

346

2433

G04CB01

ATC

finasteride; oral

1.4

9.6

475

3536

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

9.6

417

3036

SFA30

NOMESCO Finland

Three-surface restoration

1.2

9.5

1473

12747

JEA00

NOMESCO Finland

Appendectomy

1.7

9.5

184

1124

R96

ICPC

Asthma

1.5

9.5

354

2503

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

3.0

9.5

133

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.1

9.5

439

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

9.5

468

3478

R78

ICPC

Acute bronchitis/bronchiolitis

2.1

9.5

387

A03

ICPC

Fever

1.4

9.4

449

3318

K61.0

ICD-10 Finland

Anal abscess

2.7

9.4

189

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

9.4

334

2341

SPAT1210

SPAT

Application of cast or individual aid

1.7

9.4

152

885

D25

ICPC

Abdominal distension

2.3

9.4

317

JFA97

NOMESCO Finland

Other laparoscopic local operation on intestine

+∞

9.4

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.4

303

2085

R03BC03

ATC

nedocromil; inhalant

1.6

9.4

240

1571

N05CF02

ATC

zolpidem; oral

1.3

9.3

585

4517

M10.9

ICD-10 Finland

Gout, unspecified

1.5

9.3

282

1914

A41.8

ICD-10 Finland

Other specified sepsis

2.1

9.3

383

M01AC06

ATC

meloxicam; systemic, rectal

1.2

9.2

1348

11586

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

9.2

278

1887

R11

ICD-10 Finland

Nausea and vomiting

1.5

9.2

286

1953

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

9.2

218

1403

E66.8

ICD-10 Finland

Other obesity

1.7

9.1

148

862

L01

ICPC

Neck symptom/complaint

1.4

9.1

506

3833

R60.0

ICD-10 Finland

Localized oedema

1.4

9.1

478

3589

R21

ICPC

Throat symptom/complaint

1.4

9.1

516

3923

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.0

9.1

509

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

9.0

1032

8622

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

9.0

207

1321

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

9.0

298

2060

R5110, ,

SPAT

1.5

9.0

263

1772

K04

ICPC

Palpitations/awareness of heart

1.6

9.0

186

1158

WZC30

NOMESCO Finland

Teaching

1.3

9.0

600

4677

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

9.0

706

5630

U71

ICPC

Cystitis/urinary infection other

1.6

8.9

226

1475

R01AD08

ATC

fluticasone; nasal

1.3

8.9

918

7572

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

8.9

1565

13701

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

8.9

276

1885

N05BA04

ATC

oxazepam; oral

1.3

8.9

903

7441

C01AA05

ATC

digoxin; systemic

1.5

8.8

308

2151

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

8.8

257

1731

D82

ICPC

Teeth/gum disease

1.2

8.8

1127

9536

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

8.8

700

5591

R03AC12

ATC

salmeterol; inhalant

1.7

8.8

166

1010

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

8.8

148

873

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

8.7

302

2106

J01MA06

ATC

norfloxacin; oral

1.4

8.7

455

3414

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

4.1

8.7

H25.8

ICD-10 Finland

Other senile cataract

1.4

8.7

477

3607

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

8.7

384

2802

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

3.0

8.7

119

R74

ICPC

Upper respiratory infection acute

1.3

8.7

821

6701

K80

ICPC

Cardiac arrhythmia NOS

1.5

8.7

304

2126

N30.0

ICD-10 Finland

Acute cystitis

1.3

8.7

547

4226

R01AD05

ATC

budesonide; nasal

1.5

8.6

247

1657

C08CA13

ATC

lercanidipine; oral

1.3

8.6

585

4566

I84.4

ICD-10 Finland

External hemorrhoids with other complications

2.7

8.6

169

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.7

8.6

169

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

8.6

678

5403

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

8.6

545

4212

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.0

8.6

470

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

8.6

149

885

M01AB05

ATC

diclofenac; systemic, rectal

1.2

8.6

2440

22375

JFB50

NOMESCO Finland

Other resection of colon

4.6

8.6

A46

ICD-10 Finland

Erysipelas

1.3

8.6

560

4348

N28.1

ICD-10 Finland

Cyst of kidney

2.3

8.5

285

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

8.5

390

2862

R03BA01

ATC

beclometasone; inhalant

1.4

8.5

483

3670

SPAT1240

SPAT

Therapeutic discussion

1.5

8.5

260

1768

K29.1

ICD-10 Finland

Other acute gastritis

2.5

8.5

211

C10AA01

ATC

simvastatin; oral

1.2

8.5

1850

16521

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

8.5

111

607

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

8.5

122

687

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

3.2

8.5

100

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.8

8.4

127

725

R4110, ,

SPAT

1.4

8.4

327

2331

B02AA02

ATC

tranexamic acid; systemic

1.4

8.4

421

3136

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

8.4

402

2972

A10AB05

ATC

insulin aspart; parenteral

1.5

8.4

269

1848

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

8.4

104

559

A07AA02

ATC

nystatin; oral

1.5

8.4

222

1465

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

8.4

611

4820

J01DA06

ATC

[U] cefuroxime

1.4

8.4

471

3577

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

8.3

204

1325

N06AB10

ATC

escitalopram; oral

1.3

8.3

565

4415

Z31.5

ICD-10 Finland

Genetic counselling

1.7

8.3

136

797

D04

ICPC

Rectal/anal pain

2.4

8.2

239

L14

ICPC

Leg/thigh symptom/complaint

1.5

8.2

282

1963

A10BJ02

ATC

liraglutide; parenteral

1.9

8.2

513

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.5

8.2

209

UJF02

NOMESCO Finland

Peroral enteroscopy

3.3

8.2

U05

ICPC

Urination problems other

1.6

8.2

203

1320

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

8.2

161

990

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.3

8.2

265

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

8.2

352

2558

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.7

8.2

132

770

D07AC01

ATC

betamethasone; topical

1.2

8.1

1306

11303

K64.2

ICD-10 Finland

Third degree haemorrhoids

2.4

8.1

210

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

4.5

8.1

L57.0

ICD-10 Finland

Actinic keratosis

1.4

8.1

449

3400

C01BC04

ATC

flecainide; systemic

1.7

8.1

140

832

S97

ICPC

Chronic ulcer skin

1.5

8.1

240

1624

A02BA02

ATC

ranitidine; systemic

1.3

8.1

728

5902

K02.1

ICD-10 Finland

Caries of dentine

1.2

8.1

1938

17445

K07

ICPC

Swollen ankles/oedema

1.6

8.1

186

1190

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

8.1

126

728

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

2.8

8.1

141

M02AA07

ATC

piroxicam; topical

1.2

8.0

1379

12015

JFA84

NOMESCO Finland

Laparoscopic excision of lesion of colon

22.1

8.0

R93.3

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of digestive tract

3.6

8.0

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

8.0

486

3734

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

8.0

229

1539

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

1828

4032

7.25

307.65

1.6

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1095

4420

3.00

191.89

4.3

4.1

5.04

21.92

ug/l

5.16

930

3641

(3048689) Calprotectin [Mass/mass] in Stool

905

3678

2.86

152.99

2.1

146.97

152.84

ug/g

0.17

731

2859

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1710

9743

2.27

137.72

2.8

2.3

3.28

3.00

mg/l

4.17

1530

8266

(3024561) Albumin [Mass/volume] in Serum or Plasma

2508

16864

2.21

131.57

5.9

4.9

35.12

34.94

g/l

0.89

2408

15605

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2815

19871

2.26

130.16

7.2

6.4

11.25

11.79

umol/l

1.96

2701

18875

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2190

14269

2.12

120.61

3.6

2.9

131.05

150.58

ug/l

2.43

2038

12985

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3598

28749

2.75

118.22

10.2

7.9

78.79

79.79

u/l

0.52

3465

27017

(40768797) Stomach Pathology biopsy report

1050

5242

2.34

111.67

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1885

11895

2.06

109.88

3.0

2.6

59.44

66.83

u/l

0.53

1763

10935

(3044640) Blood type and Crossmatch panel - Blood

1865

11999

2.00

100.24

3.0

2.5

—

(40768804) Tissue Pathology biopsy report

2184

14967

1.96

96.36

2.5

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2436

17340

1.96

95.85

3.1

2.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1118

6078

2.14

94.25

1.6

1.5

2.59

2.60

g/l

0.00

660

3554

(3013650) Neutrophils [#/volume] in Blood by Automated count

2799

21034

1.99

92.28

10.0

9.2

4.18

4.19

e9/l

0.09

2477

18253

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1213

6858

2.08

91.82

1.3

1.2

1.36

1.85

u/ml

0.86

291

1730

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1503

9235

1.98

89.70

2.8

2.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3346

26965

2.18

89.05

5.6

4.2

14.63

13.54

mm/h

3.48

3132

24712

(3013115) Eosinophils [#/volume] in Blood

2543

18682

1.91

87.40

7.1

6.0

0.20

0.19

e9/l

0.08

2249

16163

(3006315) Basophils [#/volume] in Blood

2479

18068

1.91

87.23

6.9

5.8

0.04

e9/l

1.25

2185

15417

(3022948) Iron [Moles/volume] in Serum or Plasma

1102

6130

2.08

86.32

3.1

2.6

11.94

12.61

umol/l

2.19

1039

5697

(3031040) Bacteria [#/volume] in Urine by Automated count

3101

24406

2.03

86.29

6.0

4.8

110.13

1784.84

e6/l

3.96

372

(3001604) Monocytes [#/volume] in Blood

2466

18006

1.89

85.55

6.9

5.7

0.59

0.61

e9/l

2.07

2178

15365

(3019198) Lymphocytes [#/volume] in Blood

2508

18414

1.90

85.51

6.9

5.8

1.90

1.89

e9/l

0.07

2234

16066

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2290

16433

1.86

82.78

2.3

2.1

95.14

94.20

pmol/l

0.41

1309

8353

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1032

5710

2.07

81.33

3.0

2.6

2.37

2.28

g/l

4.96

967

5269

(40760892) CBC W Ordered Manual Differential panel - Blood

2339

16978

1.85

80.64

7.2

6.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

977

5377

2.06

77.64

3.1

2.6

20.70

22.35

2.87

871

4546

(3013826) Glucose [Moles/volume] in Serum or Plasma

2876

22469

1.89

76.31

6.2

4.8

6.90

6.82

mmol/l

0.99

2748

21178

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3962

35122

3.24

73.97

23.6

16.2

25.78

25.53

mg/l

0.19

3435

28336

(3022217) INR in Platelet poor plasma by Coagulation assay

2511

18946

1.81

73.00

22.6

17.3

1.36

1.32

inr

0.76

569

5396

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2399

17979

1.78

70.08

7.8

6.1

1.21

mmol/l

3.10

2238

16285

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

488

2126

2.47

67.86

2.8

2.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3092

25151

1.87

67.00

5.7

4.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2061

15003

1.73

64.63

4.9

3.9

54.71

80.55

ng/l

0.39

1591

11237

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1775

12416

1.74

64.02

3.5

3.1

1744.59

1502.93

ng/l

0.90

1566

10777

(3015736) pH of Urine

1956

14076

1.73

63.57

4.9

3.6

5.66

5.79

0.66

705

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2550

19771

1.74

62.96

9.1

6.9

1.21

mmol/l

3.56

2283

16738

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2723

21650

1.73

59.88

4.2

3.2

61.31

54.34

u/l

2.55

2537

19754

(40761535) Cells panel - Urine sediment

639

3295

2.11

58.90

4.6

3.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

887

5164

1.91

57.85

8.0

6.6

104.41

104.34

mmol/l

0.16

887

5159

(3011397) Hemoglobin [Presence] in Urine by Test strip

1313

8622

1.76

57.75

5.2

3.8

—

(40761511) CBC panel - Blood by Automated count

3967

36012

2.82

54.94

22.6

15.4

—

(3035350) Ketones [Presence] in Urine by Test strip

2294

17675

1.66

54.25

5.1

3.9

0.00

estimate

1.98

313

3567

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

572

2913

2.12

54.18

1.8

1.6

—

(40758558) Short blood count panel - Blood

1371

9265

1.71

53.56

7.0

6.9

—

(3033658) Prothrombin time (PT) actual/Normal

1409

9603

1.70

53.28

5.2

4.0

86.94

87.14

0.10

1379

9376

(3019550) Sodium [Moles/volume] in Serum or Plasma

4034

37073

3.20

52.06

27.5

19.1

139.69

139.67

mmol/l

0.30

3982

36159

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3660

32350

2.02

50.45

5.8

4.9

1.95

2.09

mu/l

1.35

3403

29067

(3000570) Elastase.pancreatic [Mass/mass] in Stool

294

1154

2.66

50.36

1.5

1.4

262.50

267.27

ug/g

0.15

179

687

(3023103) Potassium [Moles/volume] in Serum or Plasma

4033

37147

3.13

50.08

27.7

19.3

3.99

mmol/l

0.07

3977

36186

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1050

6697

1.76

49.84

3.1

2.9

1.02

1.16

e6/l

0.49

695

3870

(3009261) Glucose [Presence] in Urine by Test strip

2291

17882

1.62

49.45

5.2

3.9

0.00

estimate

1.08

278

3223

(3027945) Reticulocytes/100 erythrocytes in Blood

810

4797

1.85

49.20

2.5

1.79

1.80

0.08

724

4230

(3003327) Ova and parasites identified in Stool by Light microscopy

258

959

2.80

49.10

1.9

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

2254

17645

1.60

47.07

6.7

5.2

0.00

estimate

0.50

286

3313

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

663

3736

1.92

46.78

2.5

2.2

0.22

0.21

g/l

3.85

623

3479

(3019309) Folate [Moles/volume] in Red Blood Cells

1173

7839

1.69

46.45

1.9

1.8

1138.05

1171.62

nmol/l

0.56

915

5822

(3023368) Bacteria identified in Blood by Culture

1542

11132

1.61

44.54

4.8

4.4

—

(3019150) Specific gravity of Urine by Refractometry

1158

7789

1.67

44.38

6.1

4.3

1.02

kg/l

0.54

187

1205

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4027

37332

2.89

44.16

15.4

11.4

25.17

25.65

u/l

0.90

3949

35789

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3126

26681

1.67

44.16

4.7

4.0

15.04

14.99

pmol/l

0.61

2864

23831

(3021960) Folate [Moles/volume] in Serum or Plasma

1364

9588

1.63

43.79

1.7

1.6

20.05

20.46

nmol/l

0.43

1202

8075

(3023520) Reticulocytes [#/volume] in Blood

640

3644

1.89

43.51

2.6

67.62

69.16

e9/l

0.58

503

2759

(3019069) Monocytes/100 leukocytes in Blood

2167

17022

1.56

42.94

7.5

6.4

8.89

8.84

0.33

2038

15822

(3018010) Neutrophils/100 leukocytes in Blood

2173

17083

1.56

42.88

6.9

6.0

58.27

57.91

0.70

2044

15898

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

500

2633

2.02

42.70

9.4

8.4

0.70

0.67

0.94

500

2612

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1637

12078

1.58

42.61

2.5

2.2

203.77

211.45

u/l

0.11

1545

11258

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4021

37338

2.79

42.24

27.8

19.4

85.59

80.57

umol/l

8.37

4021

37326

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3725

33577

1.96

41.81

20.2

15.5

74.15

75.64

ml/min/173m2

4.19

3221

27894

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

777

4750

1.78

41.79

3.8

4.2

228.96

244.54

u/l

3.15

736

4474

(3006504) Eosinophils/100 leukocytes in Blood

2150

16931

1.55

41.60

7.2

6.1

2.83

2.85

0.13

2028

15717

(3002030) Lymphocytes/100 leukocytes in Blood

2191

17334

1.55

41.46

7.3

6.2

26.47

26.82

0.73

2064

16142

(3014111) Lactate [Moles/volume] in Serum or Plasma

620

3551

1.88

41.22

7.6

6.6

1.31

1.35

mmol/l

0.33

605

3472

(3015377) Calcium [Moles/volume] in Serum or Plasma

1757

13250

1.56

41.12

3.7

3.5

2.35

mmol/l

0.42

1560

11467

(3003396) Base excess in Arterial blood by calculation

782

4818

1.77

40.85

7.7

6.9

0.94

1.11

mmol/l

0.65

639

3803

(36660697) Celiac disease serology panel - Serum

472

2480

2.02

40.46

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

778

4829

1.75

39.46

7.7

6.9

12.13

12.16

kpa

0.06

748

4612

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

778

4829

1.75

39.46

7.7

6.9

5.07

5.09

kpa

0.26

751

4612

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

801

5013

1.74

39.46

10.9

7.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1397

10070

1.58

39.42

3.3

2.8

5952.38

5732.75

umol/l

0.06

1232

8628

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

395

1979

2.10

38.47

1.6

1.7

1.61

1.56

g/l

0.39

356

1697

(3022096) Basophils/100 leukocytes in Blood

2081

16460

1.52

38.13

7.2

6.1

0.69

0.67

1.15

1967

15261

(3007461) Platelets [#/volume] in Blood

4077

38326

3.14

38.07

35.9

24.0

243.80

244.90

e9/l

0.49

4017

37253

(3024731) MCV [Entitic volume]

4077

38331

3.14

37.96

35.8

23.9

91.70

91.58

0.97

4052

37697

(3026361) Erythrocytes [#/volume] in Blood

4077

38334

3.14

37.90

36.0

24.0

4.36

4.43

e12/l

15.28

4010

37114

(3000963) Hemoglobin [Mass/volume] in Blood

4077

38341

3.13

37.75

36.1

24.1

131.29

134.09

g/l

26.25

4052

37716

(3016502) Oxygen saturation in Arterial blood

709

4335

1.76

37.75

8.1

7.2

96.11

95.52

2.86

694

4174

(3010813) Leukocytes [#/volume] in Blood

4076

38331

3.11

37.65

36.0

24.0

6.88

6.78

e9/l

1.29

4009

37106

(3035941) MCH [Entitic mass]

4076

38332

3.11

37.63

35.8

23.9

30.39

30.43

0.81

4051

37699

(3009542) Hematocrit [Volume Fraction] of Blood

4073

38303

3.06

37.32

36.1

24.1

39.05

39.88

5.76

3901

35487

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3805

34797

1.99

37.20

5.9

5.0

6.13

6.05

mmol/l

3.45

3539

31206

(3013512) EKG study

1575

11781

1.54

37.13

5.0

4.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

692

4227

1.76

36.89

3.0

2.8

7.50

9.00

umol/l

1.41

611

3702

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

592

3468

1.82

36.30

2.9

2.4

71.66

38.71

u/l

0.47

525

2959

(3018095) Leukocytes [#/volume] in Urine

1748

13418

1.52

36.27

4.7

3.9

74.48

112.80

e6/l

1.38

1276

9711

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1083

7476

1.60

36.12

3.2

2.46

mmol/l

0.52

964

6549

(3002173) Hemoglobin [Mass/volume] in Arterial blood

657

3982

1.77

35.90

8.6

7.7

117.25

120.59

g/l

4.41

648

3872

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3685

33428

1.83

35.86

7.9

6.3

41.25

40.50

mmol/mol

4.91

3470

30496

(3037522) Nuclear Ab [Titer] in Serum

720

4494

1.73

35.43

1.4

1.3

644.19

523.16

titre

0.79

172

975

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1114

7802

1.58

34.71

2.0

1.7

1.36

1.40

mg/l

0.12

885

6050

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1918

15114

1.49

34.48

2.5

2.2

80.19

79.25

nmol/l

0.75

1715

13285

(3000991) Gas panel - Venous blood

566

3339

1.80

33.75

9.4

8.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

804

5230

1.66

33.74

6.9

5.8

1.06

1.03

mmol/l

1.59

747

4842

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3661

33343

1.76

32.48

4.8

4.2

1.33

1.29

mmol/l

3.12

3371

29821

(3026008) Bacteria identified in Urine by Culture

1596

12222

1.49

32.41

3.7

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1442

10835

1.50

32.04

3.8

3.3

0.40

0.47

e6/l

0.72

1156

8315

(3028026) IgM [Mass/volume] in Serum or Plasma

398

2135

1.95

31.87

1.7

1.9

1.49

1.38

g/l

0.31

367

1933

(3007853) Bacteria identified in Skin by Aerobe culture

685

4334

1.69

31.77

2.0

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

472

2685

1.85

31.58

2.6

2.7

10.79

10.53

g/l

0.53

434

2445

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3845

35618

1.94

31.23

6.1

5.4

2.55

2.66

mmol/l

10.92

3590

32264

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

604

3716

1.73

30.98

2.8

2.4

5.81

7.08

ug/l

1.44

537

3236

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

909

6217

1.59

30.79

3.5

3.1

2.18

2.24

e6/l

0.08

562

3417

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

529

3139

1.78

30.77

2.7

59.57

62.25

ml/min/173m2

0.99

235

1313

(3013139) Helicobacter pylori Ag [Presence] in Stool

430

2403

1.88

30.38

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

258

1202

2.22

30.09

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3770

34775

1.82

30.07

5.4

4.8

4.46

4.56

mmol/l

7.32

3529

31677

(3020630) Protein [Mass/volume] in Serum or Plasma

581

3584

1.72

29.41

2.8

2.6

66.13

66.16

g/l

0.03

537

3254

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3741

34483

1.77

29.18

5.3

4.7

1.45

1.46

mmol/l

0.62

3478

31157

(3014765) Yersinia sp identified in Stool by Organism specific culture

223

991

2.32

29.11

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

276

1344

2.13

28.79

3.4

3.0

0.32

g/l

0.01

125

550

(3020891) Body temperature

322

1661

2.02

28.77

5.9

4.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

223

997

2.31

28.70

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

220

979

2.32

28.62

1.4

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

509

3058

1.76

28.24

3.9

3.1

4.36

4.53

kpa

1.08

495

2959

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

941

6600

1.55

28.21

2.1

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

303

1541

2.04

28.14

5.2

4.0

24.64

24.89

mmol/l

0.76

284

1410

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

296

1496

2.05

27.96

2.9

0.34

u/ml

0.04

179

862

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

291

1464

2.06

27.83

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2169

17972

1.43

27.48

2.7

2.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

248

3.64

27.44

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1692

13415

1.44

27.29

5.6

4.2

—

(3042936) Bacteria identified in Isolate by Culture

803

5472

1.58

27.23

2.1

2.0

—

(3025941) Bacteria identified in Stool by Culture

337

1814

1.93

26.59

1.5

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

390

2206

1.85

26.40

9.6

8.7

24.24

24.29

mmol/l

0.12

373

2145

(3021447) Carbon dioxide [Partial pressure] in Venous blood

589

3751

1.66

26.27

4.6

3.7

5.81

5.83

kpa

0.21

576

3643

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

505

3096

1.72

25.96

4.4

3.8

100.29

95.19

ng/l

0.54

441

2621

(36304419) Bacteria [Presence] in Urine

1356

10405

1.45

25.69

3.8

3.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

344

1890

1.89

25.49

3.2

2.6

1.14

1.18

0.35

344

1876

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

293

1525

1.99

25.48

3.5

3.4

501.13

3603.11

u/ml

0.99

259

1295

(3020779) Urea [Moles/volume] in Serum or Plasma

580

3720

1.65

25.09

9.8

7.1

11.07

10.50

mmol/l

1.03

554

3533

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1453

11356

1.43

24.66

3.8

3.3

34.99

37.29

u/l

0.34

1369

10729

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

335

1845

1.89

24.62

3.2

2.6

0.67

0.64

0.81

335

1833

(3002032) Base excess in Venous blood by calculation

581

3746

1.64

24.58

4.7

3.7

1.78

1.98

mmol/l

0.68

505

3177

(3029937) Albumin [Presence] in Urine by Test strip

1267

9665

1.45

24.53

5.9

4.3

0.00

estimate

0.88

270

3167

(3004716) Salmonella sp identified in Stool by Organism specific culture

266

1366

2.01

24.01

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

199

915

2.23

23.96

1.2

120.00

90.48

titre

0.32

(3017143) Hepatitis C virus Ab [Presence] in Serum

495

3086

1.68

23.82

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

191

872

2.25

23.40

1.5

1.4

—

(4200892) Spirometry reversibility

446

2716

1.72

23.39

1.5

1.4

—

(3022313) Gas panel - Capillary blood

326

1813

1.87

23.22

5.1

3.8

—

(3034770) Mitochondria Ab [Titer] in Serum

198

927

2.19

22.81

1.2

674.29

971.00

titre

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

873

6269

1.50

22.78

2.3

2.0

30.06

29.88

0.38

857

6077

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

416

2506

1.73

22.66

1.9

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

303

1660

1.89

22.61

1.5

4.54

17.91

u/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

511

3302

1.62

21.25

1.5

—

(3019060) Gas panel - Arterial blood

452

2832

1.67

21.24

5.0

4.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

474

3009

1.65

21.16

2.8

2.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

212

1050

2.07

21.13

1.8

1.4

14.98

18.61

iu/ml

—

(3002582) Erythrocytes [#/volume] in Urine

1470

11753

1.39

20.99

4.0

3.4

98.24

75.76

e6/l

0.16

1164

9097

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

398

2422

1.71

20.85

4.7

3.6

1.24

1.95

mmol/l

3.14

305

1788

(3012095) Magnesium [Moles/volume] in Serum or Plasma

888

6505

1.46

20.71

3.6

3.2

0.81

mmol/l

0.72

841

6047

(3002385) Erythrocyte distribution width [Ratio]

3264

29743

1.44

20.32

25.8

19.3

16.62

15.31

17.88

3233

29197

(3020682) Albumin/Creatinine [Ratio] in Urine

1581

12869

1.37

19.91

4.2

3.8

13.05

9.49

mg/mmol

1.69

1072

8052

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

197

3.49

19.86

1.4

1.2

—

(3009343) pH of Capillary blood

406

2519

1.68

19.76

4.8

3.7

7.41

7.42

0.52

325

(3019225) pH of Specimen

607

4151

1.54

19.70

5.5

4.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

200

3.44

19.42

1.4

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

656

4588

1.51

19.13

1.9

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

316

1846

1.77

19.10

5.1

3.9

47.54

47.98

0.12

316

1824

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

408

2557

1.66

19.08

4.8

3.7

5.15

kpa

0.03

387

2428

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

255

1402

1.87

18.80

2.3

2.2

383.32

620.59

ug/l

0.82

243

1327

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

793

5781

1.46

18.75

1.3

37.66

37.28

iu/ml

0.02

265

1793

(3044889) 12 lead EKG panel

2905

26109

1.36

18.38

5.0

4.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

645

4560

1.49

17.74

1.9

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

222

1189

1.92

17.74

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

1072

8322

1.39

17.65

2.9

2.7

4.33

5.04

e6/l

1.53

949

7468

(3005570) Glucose [Moles/volume] in Urine

359

2.68

17.60

2.1

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

121

516

2.38

17.43

1.6

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

688

4944

1.47

17.41

4.9

4.8

33.04

33.18

0.13

527

3233

(3024522) Salmonella sp identified in Specimen by Organism specific culture

122

523

2.37

17.37

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

121

517

2.38

17.35

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

121

520

2.37

17.13

1.6

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

545

3753

1.52

16.97

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

122

529

2.35

16.93

1.6

1.4

—

(3018418) pH of Serum or Plasma

1444

11818

1.34

16.75

5.1

4.1

7.40

0.41

192

2247

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

234

1300

1.85

16.70

1.5

110.00

281.94

titre

1.40

(3012516) Albumin [Mass/volume] in Urine

1485

12212

1.33

16.65

3.6

3.2

289.29

334.47

mg/l

0.18

998

7729

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

368

2326

1.64

16.60

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

1511

12472

1.33

16.46

3.5

3.2

7.15

7.28

mmol/l

0.61

1294

10328

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

119

518

2.34

16.38

1.6

1.4

—

(3002256) Pathology report gross observation

692

5039

1.45

16.24

1.4

1.3

—

(3021589) Normoblasts [#/volume] in Blood

1870

15940

1.31

16.07

11.9

10.2

0.00

e9/l

1.07

1560

12989

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

738

5466

1.42

15.75

1.3

1.2

9.68

14.17

u/ml

0.85

272

1990

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1694

1.72

15.68

2.7

2.3

3.53

3.69

g/l

1.46

253

1531

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1695

1.72

15.65

2.7

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1697

1.72

15.58

2.7

2.3

7.41

7.48

g/l

0.32

254

1532

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

189

1017

1.90

14.92

1.6

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

472

3246

1.51

14.70

1.9

1.7

1.65

1.55

1.32

397

2757

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

264

1581

1.71

14.61

2.6

2.3

2.95

2.97

g/l

0.12

235

1418

(3008152) Bicarbonate [Moles/volume] in Arterial blood

401

2666

1.56

14.59

8.1

6.8

24.83

24.55

mmol/l

0.95

394

2537

(4035726) Immunohistochemistry procedure

507

3546

1.49

14.54

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

162

843

1.96

14.14

2.8

2.7

35.00

34.63

umol/l

0.06

143

752

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

279

2.68

13.85

1.3

1.4

—

(3000494) Fungus identified in Specimen by Culture

597

4351

1.43

13.79

1.6

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

238

1410

1.73

13.70

3.6

3.3

35.48

60.18

mg/l

1.58

207

1149

(3034860) Kappa light chains.free [Mass/volume] in Serum

238

1412

1.73

13.63

3.6

3.3

112.21

92.94

mg/l

0.14

206

1150

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

276

2.67

13.60

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

260

1585

1.68

13.48

2.7

2.3

10.25

10.19

g/l

0.07

228

1406

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

211

2.92

13.42

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

211

2.92

13.42

1.4

—

(3003338) MCHC [Mass/volume]

3061

28204

1.31

13.35

31.2

21.5

330.69

331.75

g/l

8.83

3048

28002

(3024980) IgG subclass 4 [Mass/volume] in Serum

114

534

2.17

13.24

1.9

1.6

0.73

0.86

g/l

0.56

406

(3026782) Osmolality of Urine

991

7901

1.33

13.12

3.6

3.0

532.87

540.69

mosm/kgh2o

0.57

849

6774

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

231

1376

1.72

13.05

3.6

3.3

8.17

2.31

ratio

0.39

102

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

345

2274

1.56

13.02

10.5

9.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

566

4134

1.43

12.87

1.3

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1321

1.73

12.85

2.6

2.1

37.38

37.46

g/l

0.08

191

1157

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

239

1444

1.69

12.82

2.8

2.3

1.05

1.00

g/l

0.07

209

1244

(3036481) Cortisol [Moles/volume] in Serum or Plasma

462

3256

1.47

12.69

2.3

375.43

372.52

nmol/l

0.11

426

2960

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

518

2.15

12.62

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

102

470

2.20

12.36

1.1

1.54

g/l

0.05

418

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1643

14106

1.27

12.21

6.0

5.4

4.38

3.72

ug/l

0.13

1497

12574

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

138

718

1.95

12.10

6.4

5.1

509.91

4113.95

iu/ml

0.79

103

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

214

1280

1.71

11.93

1.1

0.93

1.28

u/ml

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

273

1742

1.61

11.83

2.2

1.9

1.35

2.41

ug/l

1.70

248

1524

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

165

918

1.83

11.79

3.1

3.3

64.83

756.54

u/ml

1.70

151

842

(3027456) Digoxin [Moles/volume] in Serum or Plasma

165

919

1.83

11.75

3.3

3.1

0.77

0.82

nmol/l

0.93

137

694

(3045424) Erythrocytes [Presence] in Urine

125

637

1.99

11.65

1.7

1.5

—

(3006462) Nitrate [Presence] in Urine

184

2.90

11.63

5.5

3.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

131

679

1.96

11.63

1.4

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

182

1050

1.77

11.53

3.4

3.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

142

763

1.89

11.33

1.3

1.2

56.00

258.75

titre

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

210

1268

1.69

11.31

2.8

2.2

0.02

0.03

g/l

0.30

195

1160

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

313

2090

1.54

11.14

1.4

1.3

70.66

62.13

au/ml

0.21

128

(3005322) IgE [Units/volume] in Serum or Plasma

285

1876

1.56

10.82

1.4

1.3

161.01

201.44

u/ml

0.86

258

1712

(3027135) IgG subclass 1 [Mass/volume] in Serum

334

2.33

10.82

1.6

1.4

6.68

7.18

g/l

0.58

236

(3024139) IgG subclass 3 [Mass/volume] in Serum

334

2.33

10.82

1.6

1.4

0.37

0.41

g/l

0.40

236

(3028192) IgG subclass 2 [Mass/volume] in Serum

334

2.33

10.82

1.6

1.4

2.67

2.96

g/l

0.81

235

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

197

1184

1.70

10.81

2.7

2.2

0.00

g/l

0.50

182

1081

(3004616) Nuclear Ab [Presence] in Serum

424

2.17

10.78

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

264

1711

1.58

10.73

2.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

296

1969

1.54

10.73

1.4

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1097

9090

1.28

10.54

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

465

2.09

10.31

1.8

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

227

1434

1.62

10.28

2.7

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

143

797

1.82

10.21

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

192

1165

1.68

10.18

2.8

2.2

0.00

g/l

-0.00

181

1080

(3049717) Cytology report of Urine Cyto stain

262

1716

1.56

10.18

2.9

2.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

170

1000

1.73

10.11

1.6

0.13

9.79

iu/ml

0.92

219

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

335

2317

1.48

10.09

2.6

2.4

20.09

23.39

au/ml

0.17

133

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

173

1025

1.72

10.02

2.3

2.4

3.65

3.60

g/l

0.16

163

972

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

379

2.19

9.94

1.5

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1028

8505

1.28

9.90

1.8

1.7

80094107.06

26240131.14

pmol/l

1.15

854

6917

(4062490) Immunoglobulin typing, IgG

339

2.23

9.61

1.6

1.4

—

(3044927) Protein electrophoresis panel - Urine

454

2.05

9.44

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

288

1962

1.50

9.35

3.0

3.2

4.35

4.39

pmol/l

0.22

255

1711

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

383

2.14

9.30

3.3

3.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

404

2.10

9.24

1.5

—

(3000492) Spirometry study

429

3158

1.40

9.23

1.6

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

255

1699

1.53

9.19

2.2

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

187

2.64

9.08

2.3

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

101

524

1.95

9.03

1.5

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

211

2.53

9.03

8.2

13.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

257

2.35

8.75

1.3

1.4

29.20

33.73

u/l

0.48

208

(3000475) Leukocytes [#/volume] in Synovial fluid

159

961

1.68

8.61

1.7

1.6

12767.63

12918.61

e6/l

0.02

110

691

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

173

1070

1.64

8.57

1.5

1.4

—

(3037756) Immunofixation for Serum or Plasma

153

920

1.69

8.45

1.6

—

(3006270) Folate [Moles/volume] in Blood

346

2.13

8.37

1.3

1.2

335.68

349.98

nmol/l

0.24

282

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

524

1.91

8.37

1.3

0.65

0.66

nmol/l

0.16

501

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

463

1.96

8.28

1.3

—

nmol/l

—

(3036489) Thrombin time

202

1309

1.57

8.27

2.0

1.9

22.17

21.66

0.31

186

1168

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

152

919

1.68

8.24

1.3

1.2

30.47

41.03

u/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

200

1295

1.57

8.22

1.2

0.33

1.41

u/ml

2.03

122

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

112

625

1.81

8.04

1.3

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

124

716

1.75

7.95

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

940

7871

1.25

7.93

4.9

4.0

226.88

489.19

ng/l

1.25

798

6613

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

135

799

1.71

7.93

1.1

7.82

8.68

u/ml

0.07

(40768443) Skin Pathology biopsy report

251

1729

1.48

7.75

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

231

1574

1.49

7.54

2.0

1.8

—

(4146454) Self-monitoring of blood glucose

472

1.90

7.52

2.5

2.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1299

11320

1.21

7.41

5.1

4.6

22.00

21.97

0.02

731

5934

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

271

2.19

7.36

1.1

1.2

105.71

108.67

titre

—

(3017704) Immunofixation for Urine

233

2.29

7.34

1.4

1.6

—

(21494434) Karyotype in Bone marrow

393

1.98

7.29

1.1

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

513

1.85

7.29

2.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

140

857

1.66

7.28

1.2

1.95

6.67

u/ml

0.70

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

528

1.84

7.26

1.3

0.12

0.31

nmol/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

485

1.87

7.26

1.5

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

228

2.30

7.25

2.9

2.1

15.46

23.06

umol/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

110

632

1.76

7.21

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

530

1.83

7.18

3.2

2.1

20.48

25.38

mg/l

0.49

128

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

100

560

1.80

7.14

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

161

1028

1.59

7.07

1.4

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

151

950

1.61

7.05

2.3

207.64

204.13

0.17

144

906

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

419

1.93

7.04

1.9

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

462

1.88

7.02

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

952

8082

1.23

6.97

3.2

0.81

0.79

ug/l

0.11

737

5720

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

140

868

1.63

6.94

1.2

4.84

7.35

u/ml

0.37

149

(3000093) Morphology [Interpretation] in Blood Narrative

373

1.97

6.91

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

133

815

1.65

6.91

1.5

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

539

1.80

6.82

1.3

1.4

115.52

120.30

u/ml

0.17

113

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

481

1.85

6.82

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

525

1.81

6.79

2.4

2.3

105.74

105.29

mmol/l

0.51

517

(3041354) Potassium [Moles/volume] in Venous blood

525

1.81

6.79

2.4

2.3

4.05

4.09

mmol/l

0.40

517

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

159

1024

1.57

6.75

2.2

2.1

91.28

89.57

0.44

152

987

(3011985) Renin [Units/volume] in Plasma

500

1.82

6.63

1.5

1.4

85.31

59.79

mu/l

0.39

443

(40768441) Liver Pathology biopsy report

251

2.17

6.59

1.5

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

284

2.09

6.58

1.4

1.1

42.17

36.96

u/ml

—

(3023419) Bacteria identified in Sputum by Culture

107

632

1.71

6.40

2.7

2.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

118

716

1.67

6.39

1.2

1.11

6.55

u/ml

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

566

1.75

6.35

2.7

2.5

304.88

1969.28

u/ml

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

255

2.13

6.34

1.0

279.39

288.72

mg/l

0.44

223

(3017732) Neutrophils [#/volume] in Blood

322

2409

1.36

6.30

3.4

3.2

6.77

5.41

e9/l

0.43

241

1843

(3017446) Testosterone [Moles/volume] in Serum or Plasma

327

2453

1.36

6.29

2.4

2.1

11.84

12.13

nmol/l

0.22

282

2131

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

539

1.76

6.25

2.1

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

518

1.77

6.21

1.1

1.2

270.77

296.22

u/ml

0.32

304

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

133

842

1.60

6.10

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

133

842

1.60

6.10

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

376

1.90

6.10

1.6

1.3

105117.00

106692.08

e6/l

0.01

263

(3042111) Morphology [Interpretation] in Bone marrow Narrative

121

749

1.63

6.09

1.4

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

177

2.33

5.98

1.2

174.64

335.14

u/l

1.41

165

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

337

1.94

5.95

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

337

1.94

5.95

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

337

1.94

5.95

1.6

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

212

2.18

5.77

2.1

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

141

918

1.55

5.76

1.8

1.9

13.11

11.75

mg/l

1.10

130

841

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

2.51

5.69

1.7

2.3

557.20

21958.30

u/ml

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

466

1.77

5.66

1.2

1.3

268.04

298.69

pmol/l

0.55

397

(3010375) cycloSPORINE [Mass/volume] in Blood

158

2.35

5.56

35.2

24.4

121.12

113.13

ug/l

0.31

128

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.82

5.53

1.9

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

440

1.79

5.53

4.0

4.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

100

2.71

5.42

8.9

6.2

59.81

73.52

1.48

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

101

617

1.65

5.39

1.7

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

101

617

1.65

5.39

1.7

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

107

2.63

5.30

1.1

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

277

2090

1.35

5.17

3.1

2.9

0.19

0.28

e6/l

0.88

269

2048

(1761482) Bacteria [#/volume] in Urine by Culture

156

1068

1.48

5.08

5.3

4.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

108

685

1.59

4.99

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

554

1.66

4.96

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

464

3774

1.26

4.94

3.2

3.0

235.15

210.83

ng/l

0.55

426

3458

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.67

4.92

1.8

2.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

148

1015

1.47

4.80

2.4

2.2

179.68

93.28

ug/min

1.22

602

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

343

1.82

4.74

1.6

22.07

24.55

u/ml

0.24

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

538

1.65

4.73

1.9

181.19

194.40

pmol/l

0.62

499

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

141

962

1.48

4.70

3.0

2.9

1.93

1.68

mg/l

2.11

127

868

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

344

1.81

4.70

1.0

1.1

2.71

2.76

u/ml

0.02

124

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

107

689

1.57

4.66

1.3

1.2

30.11

41.37

u/l

0.81

598

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

206

1513

1.38

4.59

1.7

1.8

39.94

38.61

u/l

0.46

183

1305

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

154

2.22

4.52

2.3

2.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

284

1.88

4.49

1.4

281.67

413.70

titre

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

505

4192

1.23

4.48

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

424

1.71

4.47

3.5

3.7

57.12

56.71

0.05

348

(3047189) Immunofixation for 24 hour Urine

215

2.01

4.45

1.3

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.66

4.31

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

422

1.69

4.28

3.7

3.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

423

1.69

4.25

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

423

1.69

4.25

1.7

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.04

4.23

1.1

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

109

724

1.52

4.17

1.3

1.6

0.88

0.83

nmol/l

0.30

600

(4094501) Cardiovascular stress test using bicycle ergometer

144

1012

1.44

4.16

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

221

1.96

4.15

2.6

2.0

412.55

501.55

e6/l

0.74

189

(3014148) Varicella zoster virus Ab [Titer] in Serum

265

1.86

4.07

1.1

—

(3042631) Mycobacterium sp identified in Specimen

584

1.57

4.07

2.5

2.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.20

4.05

1.3

1.5

43.33

42.53

umol/l

0.04

(3032057) Clostridioides difficile [Presence] in Stool

2.46

4.04

1.7

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

182

2.04

4.03

1.0

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

398

3259

1.24

4.01

4.3

4.1

1.08

0.93

0.58

176

1179

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

210

1.96

4.00

2.7

2.1

0.24

0.22

e9/l

0.29

187

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

555

1.58

4.00

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

156

2.12

3.99

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

163

1181

1.40

3.99

4.0

3.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

297

1.79

3.95

1.6

1.7

1255.17

2103.68

u/l

0.33

107

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

457

1.63

3.89

1.2

4.42

4.88

u/ml

0.10

191

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

623

1.54

3.88

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

131

918

1.44

3.87

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

241

1.88

3.87

1.5

1.6

7.23

7.19

u/l

0.01

199

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

307

1.77

3.84

1.1

—

(3045142) Bone marrow Pathology biopsy report

490

1.60

3.84

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

547

1.57

3.78

6.6

12.47

12.02

mg/l

0.36

506

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

130

916

1.43

3.74

1.7

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

541

1.56

3.73

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

703

1.49

3.71

1.7

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

133

944

1.42

3.68

1.6

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

102

690

1.49

3.63

3.4

3.6

1.97

1.63

0.40

605

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

609

1.52

3.63

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

300

1.74

3.55

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

199

1.92

3.52

1.2

1.1

99.22

87.45

u/l

0.30

179

(3032773) Endomysium IgG Ab [Titer] in Serum

235

1.84

3.51

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

534

1.55

3.49

1.4

1.2

282.95

200.51

miu/ml

0.98

208

(3011648) Oxygen content in Venous blood

311

1.71

3.42

1.9

10.10

10.91

0.71

311

(3026250) Tacrolimus [Mass/volume] in Blood

133

2.11

3.39

29.8

32.5

7.12

7.34

ug/l

0.16

120

(3041672) Baker's yeast Ab [Presence] in Serum

7.01

3.36

1.0

—

(3024928) Oxygen saturation in Venous blood

119

844

1.42

3.34

3.7

3.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

210

1.87

3.34

1.5

9.99

6.12

u/l

0.41

177

(3016650) Hepatitis A virus Ab [Presence] in Serum

508

1.55

3.34

1.1

—

(3021788) Differential panel - Synovial fluid

102

704

1.46

3.31

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

155

2.01

3.29

3.4

2.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

111

783

1.43

3.23

1.2

—

(3011412) CD3 cells [#/volume] in Blood

325

1.67

3.20

2.4

2.0

0.99

1.12

e9/l

0.74

294

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

652

1.47

3.19

1.2

11.63

43.95

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

579

1.50

3.18

1.3

13.40

11.24

u/l

0.61

466

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

158

1189

1.34

3.13

1.7

1.6

—

(3000330) Specific gravity of Urine by Test strip

257

2064

1.26

3.13

4.5

3.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

356

2963

1.22

3.12

4.1

4.0

0.54

0.70

1.34

151

1010

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

656

1.46

3.10

3.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

118

2.13

3.09

3.4

2.9

26.28

22.60

mu/l

0.23

113

(3042733) HLA Ab [Presence] in Serum

2.26

3.02

4.8

5.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

308

1.66

3.00

1.9

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

465

1.54

3.00

1.2

2.69

3.38

u/ml

0.26

140

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

218

1727

1.28

2.98

3.7

4.0

74.04

67.50

u/ml

0.09

210

1664

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

198

1.83

2.93

2.8

2.5

39.79

39.71

0.01

115

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.39

2.87

1.0

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

367

3094

1.20

2.84

4.5

4.1

0.14

0.12

0.24

148

1017

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.34

2.81

2.6

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

411

3506

1.19

2.80

1.6

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

159

1.89

2.75

1.1

1.2

—

(4281824) Cell count and differential, peritoneal fluid

395

1.55

2.74

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

218

1747

1.26

2.74

5.3

5.4

0.88

0.02

213

1641

(3026692) Albumin [Mass/volume] in Peritoneal fluid

111

2.08

2.72

1.6

1.5

12.88

14.27

g/l

0.33

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

211

1.76

2.70

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

211

1.76

2.70

1.3

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

103

744

1.39

2.68

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

197

1.78

2.67

2.2

1.6

0.59

2.61

u/field

4.67

138

(3028433) Virus identified in Specimen by Culture

126

1.99

2.65

1.0

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

464

1.50

2.62

1.8

1.5

55.15

60.24

0.48

289

(3014051) Protein [Presence] in Urine by Test strip

138

1048

1.33

2.62

3.7

2.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

266

1.66

2.62

1.6

1.9

39.46

38.62

0.12

261

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

530

1.46

2.61

1.1

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

416

1.52

2.61

3.3

3.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

155

1.88

2.60

1.0

—

(3003129) Base excess in Capillary blood by calculation

107

2.06

2.56

2.1

1.9

-0.86

0.76

mmol/l

0.85

100

(3003434) Protein [Mass/volume] in Pleural fluid

624

1.42

2.56

1.6

1.5

30.05

32.04

g/l

0.80

562

(3009871) Measles virus Ab [Titer] in Serum

2.23

2.53

1.9

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

218

1767

1.25

2.51

5.4

5.3

1.62

1.61

0.08

213

1656

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.81

2.46

2.1

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

646

1.40

2.46

1.8

1.9

4.24

4.85

mmol/24h

1.26

547

(3022689) Creatine [Moles/volume] in Urine

116

1.99

2.45

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

168

1326

1.28

2.43

1.8

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

441

1.48

2.40

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

197

1.73

2.38

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.35

2.38

1.5

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

205

1.71

2.37

1.1

—

(3036603) Volume of Urine

259

1.63

2.35

1.4

1.6

1798.31

1862.30

0.25

251

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

237

1.65

2.31

2.2

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

553

1.42

2.30

1.6

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

348

1.53

2.29

1.4

1.3

—

25.93

—

(3025159) Blasts/100 leukocytes in Blood

341

2918

1.18

2.29

4.5

4.1

0.10

0.40

1.09

125

852

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.95

2.28

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

489

1.44

2.25

1.7

2.3

0.87

1.33

g/24h

1.36

240

(40768446) Kidney Pathology biopsy report

135

1.86

2.21

1.5

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

135

1.86

2.21

1.3

1.1

37.17

39.67

g/l

0.26

(3003181) Sodium [Moles/volume] in Urine

102

762

1.35

2.21

1.3

55.94

62.57

mmol/l

1.38

619

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.56

2.21

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

157

1.79

2.21

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

122

938

1.31

2.18

1.7

2.2

124.18

127.96

g/l

0.77

672

(3020491) Glucose [Moles/volume] in Blood

273

1.58

2.16

1.5

2.1

7.98

6.84

mmol/l

1.25

183

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.03

2.15

1.5

2.4

187.47

199.79

0.18

(3020911) Cortisol [Moles/time] in 24 hour Urine

108

1.95

2.15

1.0

1.5

81.33

233.30

nmol/24h

0.74

108

(3050794) Legionella sp Ab [Presence] in Serum

3.00

2.14

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.62

2.14

1.3

1.2

110.40

140.33

ug/l

—

(3000034) Microalbumin [Mass/volume] in Urine

371

1.49

2.12

3.3

3.2

20.32

30.35

mg/l

0.60

286

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.97

2.10

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

472

1.43

2.08

4.1

4.7

344.75

351.62

umol/l

0.16

405

(3044941) Cell count panel - Synovial fluid

634

1.36

2.05

1.3

1.4

—

(3024932) HLA-DR beta [Type]

1.98

2.05

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

3.08

2.01

1.1

1.0

—

3.10

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

155

1.75

1.99

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

155

1.75

1.99

1.7

—

(40761536) Microorganisms panel - Urine sediment

262

3077

0.84

1.99

5.0

4.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

122

952

1.29

1.98

1.3

—

(3004451) EKG impression Narrative

217

1.62

1.96

1.2

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

3.34

1.96

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.34

1.96

1.4

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

233

1.59

1.95

1.3

1.5

0.22

0.27

nmol/l

0.42

172

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

134

1.80

1.95

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

103

788

1.31

1.94

1.7

1.8

2.87

4.30

iu/l

2.36

255

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.55

1.94

2.0

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.97

1.93

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.45

1.93

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.25

1.90

1.1

1.3

—

(1002224) Polysomnography panel

134

1065

1.27

1.90

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1004

10784

0.91

1.90

3.3

3.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.19

1.88

1.1

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

758

1.31

1.87

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

114

1.85

1.87

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

285

1.51

1.84

5.1

5.0

22.13

49.63

u/ml

—

(3024471) HLA-A [Type]

101

1.89

1.80

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

684

1.32

1.80

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.00

1.79

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.96

1.79

1.1

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

192

1.62

1.77

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

216

1.58

1.76

1.4

1.3

1.20

1.03

u/ml

0.07

120

(3000060) B lymphocytes [#/volume] in Blood

2.09

1.75

2.3

2.0

180.00

163.33

e6/l

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

139

1.73

1.75

2.0

1.4

23.38

29.55

umol/l

2.14

134

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

106

828

1.29

1.75

1.2

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

498

1.37

1.74

1.5

36642.79

73738.62

e6/l

0.79

289

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

372

1.43

1.73

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

202

1.59

1.71

6.4

6.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

315

1.47

1.70

2.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

110

867

1.28

1.70

1.3

1.2

733.12

560.10

mg/l

0.32

103

811

(3022621) pH of Urine by Test strip

289

2509

1.16

1.69

3.5

3.1

—

(3012441) Differential panel - Pleural fluid

476

1.37

1.67

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

243

1.53

1.67

1.2

1.4

0.92

1.11

promille

0.35

182

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.16

1.66

1.3

5.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

1.60

1.65

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

157

1.66

1.65

8.5

5.2

72.16

64.91

mg/l

0.21

110

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

196

1.59

1.65

1.6

—

(40762814) Titanium [Mass/volume] in Blood

1.98

1.64

2.5

2.2

2.97

4.11

ug/l

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

127

1.74

1.63

1.5

2.3

180.55

166.54

0.30

116

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1059

9929

1.09

1.63

1.7

1.36

1.35

mmol/l

0.19

925

8192

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

197

1.58

1.62

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

197

1.58

1.62

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

353

1.42

1.60

1.2

1.3

—

(40768806) Pleura Pathology biopsy report

489

1.36

1.59

1.5

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

320

1.44

1.59

1.7

2.0

4.44

1.88

u/field

0.79

116

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.91

1.59

1.1

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

106

1.80

1.58

1.5

1.6

0.30

0.44

ug/l

0.75

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

144

1.67

1.57

1.1

698.11

415.16

ng/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

551

1.33

1.57

1.5

3253.09

1650.68

e6/l

0.50

396

(3004775) Volume in Urine collected for unspecified duration

338

1.42

1.56

2.6

2.2

812.03

628.66

1.33

214

(3048879) Bone marrow aspiration report

129

1.71

1.56

1.7

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

152

1.65

1.56

1.2

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

764

1.28

1.54

1.2

3.84

3.87

mmol/l

0.09

709

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

130

1.70

1.52

2.0

3240.06

21962.20

e6/l

0.72

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.34

1.52

1.0

1.1

187.80

270.47

nmol/l

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.16

1.50

1.1

58.67

77.00

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.16

1.50

1.5

—

(3025577) Chromium [Mass/volume] in Blood

291

1.45

1.50

2.2

2.1

1.61

2.06

ug/l

0.88

246

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

418

1.37

1.49

1.4

240.89

323.59

u/l

1.21

400

(3000012) Reticulocyte production index

635

1.30

1.49

2.0

2.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

296

3357

0.87

1.48

5.1

4.0

1.22

1.23

mmol/l

0.79

269

2934

(3023511) Choriogonadotropin [Units/volume] in Urine

132

1.67

1.45

1.7

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

132

1.67

1.45

1.4

1.2

166.92

421.03

ug/l

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.12

1.44

1.1

1.2

77.83

76.80

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

148

1.63

1.44

2.4

2.2

1579.84

5901.20

e6/l

0.40

106

(3025018) Bordetella pertussis Ab [Titer] in Serum

156

1.61

1.43

1.3

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

220

1.50

1.43

1.8

1.6

0.85

0.94

g/l

1.40

220

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

196

1.53

1.42

1.7

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

198

1696

1.18

1.41

1.2

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

149

1.61

1.40

1.1

1.2

136.92

157.07

mmol/24h

0.67

149

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.25

1.40

1.1

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

280

1.43

1.37

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

127

1.66

1.36

2.8

1.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.76

1.34

1.7

1.5

9.02

8.97

ug/l

0.02

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

1.34

0.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

145

1215

1.20

1.34

1.5

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

726

1.26

1.33

1.5

195.79

227.29

pmol/l

0.21

710

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.15

1.33

2.6

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

105

1.72

1.33

1.1

1515.61

1691.83

miu/ml

0.21

105

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

136

1134

1.21

1.33

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

192

1.51

1.31

1.4

1.3

0.95

1.16

nmol/l

0.67

148

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

283

1.42

1.31

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

225

1.47

1.31

2.2

2.0

108.00

246.11

ug/min

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

107

1.69

1.25

2.8

2.1

—

(3016750) Collection duration of Urine

236

1.44

1.24

2.6

2.1

496.39

490.86

min

0.12

171

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.40

1.24

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.40

1.24

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.22

1.24

3.8

2.4

0.38

0.50

u/field

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.77

1.22

1.1

1.2

0.87

0.70

umol/24h

—

(44813793) Dust mix specific IgE antibody measurement

212

1.47

1.22

1.2

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

313

1.38

1.22

1.4

1.5

14.37

13.14

u/l

0.61

299

(3046861) Legionella sp Ag [Presence] in Urine

2.63

1.21

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

593

1.27

1.21

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

164

1.53

1.20

6.0

4.7

40.00

63.00

u/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

453

1.31

1.19

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

289

1.39

1.19

2.1

2.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

367

1.34

1.17

1.1

1.69

1.88

u/ml

0.07

175

(3008536) Aspergillus sp Ab [Presence] in Serum

1.77

1.16

1.9

1.6

—

(3008898) HLA-B27 [Presence]

104

858

1.22

1.16

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.16

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.73

1.15

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

378

1.33

1.13

1.4

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

159

1.51

1.11

1.3

1.7

1.27

7.80

nmol/l

1.49

133

(3001893) Eosinophils/100 leukocytes in Pleural fluid

143

1.54

1.11

1.4

1.5

0.54

2.86

2.62

120

(3023383) Lactate [Moles/volume] in Pleural fluid

135

1.56

1.11

1.3

2.20

3.35

mmol/l

2.31

122

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.78

1.10

1.5

8.86

6.29

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.95

1.08

1.4

1.2

3.54

7.26

mg/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

152

1.52

1.08

1.1

1.2

—

(3051651) Icteric interference index of Serum or Plasma

236

1.40

1.06

3.1

3.5

—

(3002619) Bacteria identified in Specimen by Culture

1.79

1.04

1.3

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

271

1.37

1.04

1.4

1.5

—

(1616796) Gas panel - Central venous blood

109

916

1.20

1.03

3.4

4.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.06

1.02

2.1

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.06

1.02

2.1

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.06

1.02

2.1

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.06

1.02

2.0

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.92

1.02

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

465

1.27

1.01

1.3

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1.38

1.01

1.1

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

1.65

1.00

1.1

1.3

22.45

58.04

mu/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

180

1.45

1.00

1.3

1.4

207.45

202.15

pmol/l

0.03

180

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.88

1.00

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

239

1.38

1.00

2.6

2.9

—

(4034850) Laboratory test

138

1188

1.17

1.00

12.6

10.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

110

0.45

1.00

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

189

1.43

0.99

1.6

—

(3019977) pH of Arterial blood

240

1.38

0.98

1.9

2.5

7.41

7.42

0.21

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.18

0.98

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

292

1.34

0.97

1.5

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

173

1.45

0.97

1.5

56.44

65.66

0.57

137

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

124

1.53

0.96

1.7

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

124

1.53

0.96

1.7

2.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

250

1.36

0.95

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

383

1.28

0.92

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.67

0.91

1.3

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

184

1.42

0.91

1.2

155.54

137.88

nmol/l

0.94

184

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

185

1.41

0.89

1.3

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

439

1.26

0.88

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.65

0.88

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

161

1.43

0.86

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

247

1.34

0.85

1.1

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.94

0.84

1.8

1.3

0.65

0.83

ml/s/173m2

—

(4212803) Bone marrow aspirate examination

1.78

0.84

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.76

0.83

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.76

0.83

10.6

14.0

4.65

5.41

mmol/l

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

248

1.33

0.83

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.70

0.80

2.0

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

122

1.48

0.80

11.3

12.3

0.63

mmol/l

0.01

114

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

250

1.32

0.80

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

250

1.32

0.80

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

356

1.27

0.79

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.82

0.79

1.0

—

(3010421) pH of Blood

122

1065

1.15

0.78

5.0

4.6

7.42

0.08

108

969

(3013166) Neutrophils/100 leukocytes in Synovial fluid

131

1.45

0.78

1.4

54.59

56.50

0.07

112

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.59

0.78

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

149

1678

0.88

0.77

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

148

1.42

0.77

1.7

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

314

1.28

0.76

1.0

1.1

2.83

3.67

u/ml

0.16

136

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

183

1.37

0.75

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

209

1.34

0.75

2.5

3.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.08

0.74

1.2

2.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.08

0.74

1.6

1.0

—

(3036180) Methadone [Presence] in Urine

1.67

0.74

1.2

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

133

1.43

0.73

1.1

1.3

—

0.24

g/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.64

0.73

1.0

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

954

9163

1.05

0.73

4.4

3.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.80

0.72

1.6

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

353

1.25

0.71

1.7

1.4

26.76

29.48

0.21

217

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

101

1.49

0.70

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

143

1.40

0.70

1.5

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

527

1.20

0.70

1.1

248.21

1227.03

iu/ml

—

106

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

186

1.35

0.70

1.5

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.51

0.69

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

169

1.36

0.69

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.85

0.68

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.67

0.68

2.0

2.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

102

1.47

0.67

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

238

0.71

0.67

1.4

1.5

78.71

88.29

umol/l

1.88

238

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.63

0.66

1.1

2.21

1.77

umol/24h

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

136

1.40

0.66

1.7

2.3

67.20

144.44

umol/l

—

(3027944) Amphetamines [Presence] in Urine

376

1.23

0.65

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

131

0.61

0.63

1.1

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

306

1.24

0.62

1.0

1.1

0.63

1.32

u/ml

0.79

117

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.63

0.62

3.6

2.9

—

30.88

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.67

0.61

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

712

1.15

0.61

4.0

3.6

59.51

57.86

0.63

712

(3051387) C reactive protein [Mass/volume] in Capillary blood

845

0.86

0.60

4.9

3.6

29.71

28.72

mg/l

0.08

528

(3022475) Manganese [Moles/volume] in Blood

0.00

0.60

0.0

1.3

—

(3027008) Opiates [Presence] in Urine

380

1.21

0.60

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

703

0.85

0.58

1.5

1.3

33.39

34.87

iu/l

0.13

602

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.51

0.58

2.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

382

1.21

0.58

1.5

—

(3023410) Appearance of Cerebral spinal fluid

328

1.22

0.57

1.4

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

176

1.31

0.56

1.9

1.6

—

(3028300) Cannabinoids [Presence] in Urine

384

1.20

0.55

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

221

1.27

0.55

1.1

2.03

14.59

nmol/l

1.07

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

1.40

0.55

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

284

1.23

0.55

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

208

1925

1.08

0.53

1.2

140.90

138.89

iu/ml

0.02

682

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.52

0.52

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

241

1.25

0.52

1.6

1.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.50

0.51

1.5

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

593

1.15

0.50

2.0

1.7

284.62

305.16

mu/l

0.35

548

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

744

1.13

0.50

1.4

818.07

1331.08

e6/l

0.35

602

(3016038) Potassium [Moles/volume] in Urine

279

1.22

0.50

1.1

37.68

34.45

mmol/l

0.36

240

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

745

1.13

0.49

1.3

5.94

26.99

e6/l

1.74

569

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

455

1.17

0.49

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

108

0.65

0.48

1.1

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

163

1.29

0.48

1.4

1.56

1.57

g/l

0.05

163

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.49

0.47

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.41

0.46

1.2

1.1

86.17

84.47

—

(3003740) Influenza virus B Ag [Presence] in Specimen

319

1.19

0.45

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.43

0.45

1.4

1.5

—

(3024263) Appearance of Synovial fluid

228

1.23

0.45

1.1

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

320

1.19

0.44

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.37

0.43

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.61

0.43

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.61

0.43

1.4

1.5

6.68

8.11

mmol/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

368

1.17

0.42

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.56

0.42

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.38

0.42

1.2

1.3

93.50

82.48

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.43

0.41

1.1

16.57

16.70

umol/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

6.9

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

105

1.33

0.41

1.2

1.3

51.88

30.67

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

437

4190

1.05

0.41

4.1

3.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.47

0.40

1.2

18.40

10.74

u/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

227

0.79

0.40

3.6

4.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.40

0.0

2.5

—

(3012501) Base excess in Blood by calculation

100

911

1.10

0.40

4.9

4.8

3.06

2.74

mmol/l

0.46

640

(3005033) Fetal Nuchal fold Thickness US

105

0.67

0.39

1.1

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

106

0.66

0.39

1.1

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

106

1.32

0.39

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.39

0.38

1.0

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.34

0.38

1.6

116.44

143.72

ng/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

116

1.29

0.37

1.7

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.36

0.36

1.6

3.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.66

0.35

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.65

0.35

1.0

1.2

0.37

2.20

mmol/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.43

0.35

1.0

—

(3035880) pH of Pleural fluid

254

1.18

0.35

1.3

1.4

—

(40765096) Chromosome analysis panel by Banding

135

1.26

0.35

1.4

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

125

0.72

0.35

1.1

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

125

0.72

0.35

1.1

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

126

0.71

0.35

1.1

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

126

0.71

0.35

1.1

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.33

0.33

1.7

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.33

0.33

2.8

5.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.70

0.33

1.5

1.4

—

(3021901) Oxygen saturation in Capillary blood

790

1.09

0.31

2.6

2.9

—

(3017569) Oxygen content in Arterial blood

211

1.19

0.31

2.2

—

(40758292) HTLV I+II Ab panel - Serum

1.35

0.31

1.1

1.4

—

(40768793) Breast Pathology biopsy report

839

1.09

0.31

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

147

1.23

0.30

2.8

3.6

52.36

53.62

0.09

140

(3044007) Cell count panel - Peritoneal fluid

120

1.25

0.30

1.9

2.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.27

0.30

1.0

1.3

1442862.41

179551.55

nmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.29

0.30

1.4

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

206

0.82

0.29

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

892

1.08

0.28

2.3

2.6

15.82

16.01

0.16

465

(3044242) Glucose [Moles/volume] in Arterial blood

223

1.17

0.28

2.1

2.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

270

1.15

0.28

2.2

2.5

—

(3011288) Drugs identified in Urine by Screen method

252

1.15

0.27

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

131

1.22

0.27

1.3

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

168

1.19

0.27

1.1

0.93

1.17

u/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

215

1.16

0.26

1.0

1.1

4.84

2.53

u/ml

0.33

(40757373) Influenza virus identified in Isolate

1.28

0.26

2.1

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

394

0.89

0.26

1.1

1.3

7.40

7.61

mmol/l

0.16

332

(3008295) Osmolality of Serum or Plasma

415

0.89

0.26

1.2

1.4

279.96

276.32

mosm/kgh2o

0.38

315

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

120

1274

0.94

0.26

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

0.67

0.25

4.2

5.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

839

1.07

0.25

1.5

1.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

105

1.24

0.24

1.3

124.13

123.58

nmol/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

236

1.14

0.24

1.4

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

284

1.13

0.23

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

237

1.14

0.23

1.4

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

294

1.12

0.23

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

190

1.16

0.23

1.0

1.14

0.33

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.28

0.23

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

969

0.94

0.22

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.22

0.22

1.0

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.19

0.21

4.2

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.19

0.21

1.8

1.6

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.11

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

604

0.93

0.20

1.5

1.7

—

(3025130) Human papilloma virus identified in Specimen

270

1.11

0.18

1.8

1.7

—

(3047181) Lactate [Moles/volume] in Blood

138

1324

1.04

0.17

6.2

6.4

1.24

1.31

mmol/l

0.60

129

1174

(3014133) Dog dander IgE Ab [Units/volume] in Serum

233

1.12

0.17

1.0

1.1

3.94

2.35

u/ml

0.35

103

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

281

1.10

0.17

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

157

1.15

0.17

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.18

0.16

1.1

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

1.18

0.16

1.1

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.11

0.16

7.1

7.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.10

0.15

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

0.79

0.15

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.13

0.15

1.1

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

139

0.86

0.14

8.2

6.8

25.11

24.58

mmol/l

0.24

124

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.17

0.13

2.3

2.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

117

0.85

0.13

1.1

1.2

—

(3018572) Chloride [Moles/volume] in Blood

953

1.04

0.12

7.1

7.4

106.61

105.15

mmol/l

2.07

851

(3039000) Anion gap in Blood

953

1.04

0.12

7.1

7.4

11.02

11.24

mmol/l

0.34

851

(3034426) Prothrombin time (PT)

104

1.15

0.12

1.1

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

179

0.89

0.12

1.1

1.3

5.90

6.13

mmol/l

0.66

169

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

105

1.14

0.11

1.3

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

918

1.04

0.10

2.6

2.9

8.03

7.95

kpa

0.22

898

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.15

0.10

1.0

1.36

0.41

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

207

0.92

0.09

1.3

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

126

1.11

0.09

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.04

0.08

1.6

1.3

403.86

486.69

u/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.83

0.07

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.08

0.07

1.4

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

137

1.10

0.07

1.6

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

112

0.89

0.07

1.6

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.03

0.07

1.3

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.12

0.06

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

167

1.08

0.06

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.88

0.06

1.1

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.89

0.06

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.89

0.06

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.89

0.06

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.89

0.06

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.84

0.06

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

105

0.86

0.06

8.0

7.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

335

0.95

0.06

1.4

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

105

1029

1.02

0.05

1.6

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

257

1.05

0.05

1.5

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

546

0.97

0.05

1.9

88.40

89.41

0.61

537

(3045788) Cell count panel - Pleural fluid

437

1.03

0.04

1.4

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

1.09

0.04

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

139

0.94

0.03

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

349

1.03

0.03

1.3

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

657

1.02

0.03

2.0

1.9

1.74

1.68

mmol/l

0.23

637

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

197

1988

0.99

0.03

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

966

1.01

0.03

1.6

1.7

3.57

3.83

mg/l

0.06

724

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

181

1.05

0.03

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

102

1.08

0.03

1.1

1.0

0.28

1.15

u/ml

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

212

1.04

0.02

1.5

1.7

—

(3015183) Erythrocyte sedimentation rate

113

1.06

0.01

1.3

—

(40768795) Lymph node Pathology biopsy report

382

1.02

0.01

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

302

0.99

0.00

1.1

1.0

681.53

691.94

ng/l

0.03

192

(3043410) Blood group antigens tested for on Red Blood Cells

106

1.04

0.00

1.1

2.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

113

0.97

0.00

2.1

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

303

0.99

0.00

1.1

1.0

64.03

45.80

ng/l

0.36

195

(3040151) Glucose [Moles/volume] in Capillary blood

457

1.01

0.00

14.7

20.8

7.56

7.47

mmol/l

0.06

376

(3010726) Horse dander IgE Ab [Units/volume] in Serum

271

1.00

0.00

1.0

1.1

1.02

1.32

u/ml

0.21

134

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

301

1.00

0.00

1.1

1.0

277.29

326.45

ng/l

0.78

197

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

2.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.00

-0.00

8.0

7.6

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.96

-0.00

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.4

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.96

-0.00

2.1

2.3

113.44

145.12

nmol/l

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.5

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

1.9

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.89

-0.00

1.3

1.2

—

(3020650) Glucose [Presence] in Urine

0.98

-0.00

1.6

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.34

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

2.01

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.02

-0.00

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CAECUM and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CAECUM	1.248 [1.11, 1.4]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.036

During the follow-up period (1.1.1998 — 31.12.2019), 1399 out of 7195 females with CD2_BENIGN_CAECUM died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CAECUM	1.395 [1.23, 1.58]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 1984 out of 6799 males with CD2_BENIGN_CAECUM died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CAECUM.

N-year risk	Females	Males
1	0.101%	0.269%
5	0.735%	1.517%
10	1.712%	3.638%
15	3.252%	7.042%
20	5.608%	11.836%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CAECUM – Benign neoplasm: Caecum

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Caecum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints